Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

291 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Metabolic Syndrome in Cushing's Syndrome Patients.
Ferraù F, Korbonits M. Ferraù F, et al. Front Horm Res. 2018;49:85-103. doi: 10.1159/000486002. Epub 2018 Apr 5. Front Horm Res. 2018. PMID: 29894989 Review.
Pathogenesis of vascular complications in Cushing's syndrome.
Miljic P, Miljic D, Cain JW, Korbonits M, Popovic V. Miljic P, et al. Hormones (Athens). 2012 Jan-Mar;11(1):21-30. doi: 10.1007/BF03401535. Hormones (Athens). 2012. PMID: 22450342 Review.
[Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
Góth M, Hubina E, Korbonits M. Góth M, et al. Orv Hetil. 2005 Jan 9;146(2):51-5. Orv Hetil. 2005. PMID: 15724952 Review. Hungarian.
Several studies suggested an association between the clinical signs of the metabolic syndrome and the increased hypothalamic-pituitary-adrenal axis activity based on increased cortisol concentration at 09.00 a.m. and increased cortisol response to corticotropin. ...
Several studies suggested an association between the clinical signs of the metabolic syndrome and the increased hypothalamic-pituitary-adren …
Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment.
Putignano P, Kaltsas GA, Korbonits M, Jenkins PJ, Monson JP, Besser GM, Grossman AB. Putignano P, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3309-12. doi: 10.1210/jcem.85.9.6833. J Clin Endocrinol Metab. 2000. PMID: 10999826 Clinical Trial.
Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, Grossman AB. Newell-Price J, et al. J Clin Endocrinol Metab. 2002 Apr;87(4):1640-5. doi: 10.1210/jcem.87.4.8357. J Clin Endocrinol Metab. 2002. PMID: 11932295
Metabolic comorbidities in Cushing's syndrome.
Ferraù F, Korbonits M. Ferraù F, et al. Eur J Endocrinol. 2015 Oct;173(4):M133-57. doi: 10.1530/EJE-15-0354. Epub 2015 Jun 9. Eur J Endocrinol. 2015. PMID: 26060052 Review.
Obesity and metabolism. Preface.
Korbonits M. Korbonits M. Front Horm Res. 2008;36:ix. doi: 10.1159/isbn.978-3-8055-8430-2. Front Horm Res. 2008. PMID: 18409238 No abstract available.
The role of AMP-activated protein kinase in obesity.
Kola B, Grossman AB, Korbonits M. Kola B, et al. Front Horm Res. 2008;36:198-211. doi: 10.1159/000115366. Front Horm Res. 2008. PMID: 18230904 Review.
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
Christ-Crain M, Kola B, Lolli F, Fekete C, Seboek D, Wittmann G, Feltrin D, Igreja SC, Ajodha S, Harvey-White J, Kunos G, Müller B, Pralong F, Aubert G, Arnaldi G, Giacchetti G, Boscaro M, Grossman AB, Korbonits M. Christ-Crain M, et al. FASEB J. 2008 Jun;22(6):1672-83. doi: 10.1096/fj.07-094144. Epub 2008 Jan 15. FASEB J. 2008. PMID: 18198220
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.
Kola B, Christ-Crain M, Lolli F, Arnaldi G, Giacchetti G, Boscaro M, Grossman AB, Korbonits M. Kola B, et al. J Clin Endocrinol Metab. 2008 Dec;93(12):4969-73. doi: 10.1210/jc.2008-1297. Epub 2008 Sep 9. J Clin Endocrinol Metab. 2008. PMID: 18782871
291 results
Jump to page
Feedback